Traded Jan 27 · filed 2 days laterNot under a reported trading plan
A Argan director sold $1.8M of Argan shares. The filing does not indicate a pre-arranged trading plan.
Loading…
Traded Jan 20, 2026 · Filed Jan 21, 2026
A Argan director sold $1.03M of Argan shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,027,620
Shares × reported transaction price
47 days after results of Dec 4, 2025, 65 days before results of Mar 26, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −6.5% | +0.7% | −7.3% |
| 30 days | +16.1% | −1.0% | +17.1% |
| 90 days | +71.3% | +3.2% | +68.1% |
| 180 days | +59.2% | +8.6% | +50.6% |
Past results only. Not a forecast.
Traded Jan 27 · filed 2 days laterNot under a reported trading plan
A Argan director sold $1.8M of Argan shares. The filing does not indicate a pre-arranged trading plan.
Traded Jan 21 · filed 2 days laterNot under a reported trading plan
A Argan director sold $7.35M of Argan shares. The filing does not indicate a pre-arranged trading plan.
Traded Jan 16 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.